Clinical Trials · NCT02078323

Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients

Phase
N/A
Recruitment status
Completed
Sponsor
Augusta University
Enrollment
39
Start date
Feb 2014
Locations
1 site, United States
Primary endpoint
1: Change from baseline in Prolongation and normalization of anal CEP and rectal CEP responses at 10 weeks.
View Linaclotide compound reference